Yehuda Handelsman, MD

Medical Director & Principal Investigator
Metabolic Institute of America
Tarzana, California, United States

Disclosure information not submitted.

Presentation(s):

• MON-515 - Characterization of Individuals With Resistant Hypertension and Post–Dexamethasone Suppression Test Cortisol <1.2, 1.2–1.8, and >1.8 µg/dL: Results From the MOMENTUM Study

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT

• MON-516 - Endogenous Hypercortisolism in Individuals With Resistant Hypertension and Difficult-to-control Type 2 Diabetes: Results From two Large, Prospective Studies

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT